
BASF and Oxidium Technologies LLC complete sale and purchase transaction for Aseptrol biocide business
BASF Corporation and Oxidium Technologies LLC today announced an agreement under which Oxidium will acquire BASF’s Aseptrol® technology portfolio. Originally acquired by BASF from Engelhard in 2006, the Aseptrol chlorine dioxide product line is widely used in applications such as water purification, disinfection, and dental line cleaning.




